News

Law

Asset Management

Investment Banking

Wealth

Hedge Funds

People

Newsletters

Events

Lists

Investment Banking

Zaoui brothers’ Spac Odyssey takes drugmaker public in €1.5bn deal

Michael and Yoël Zaoui’s Odyssey Acquisition will combine with BenevolentAI in a deal that values the company at €1.5bn
Michael and Yoël Zaoui’s Odyssey Acquisition will combine with BenevolentAI in a deal that values the company at €1.5bn

Investment banking brothers, Michael and Yoël Zaoui, are set to take a UK startup that uses artificial intelligence to develop drugs public through their blank-cheque company unveiled in June.

Odyssey Acquisition, the Zaoui brothers' €300m special purpose acquisition company, will combine with BenevolentAI in a deal that values the company at €1.5bn, according to a statement from the firm.

WSJ Logo